» Articles » PMID: 22049216

Predicting Clinical Behaviour of Breast Phyllodes Tumours: a Nomogram Based on Histological Criteria and Surgical Margins

Overview
Journal J Clin Pathol
Specialty Pathology
Date 2011 Nov 4
PMID 22049216
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To define a predictive model for clinical behaviour of breast phyllodes tumours (PT) using histological parameters and surgical margin status.

Methods: Cases of breast PT diagnosed in the Department of Pathology Singapore General Hospital between January 1992 and December 2010 were stratified into benign, borderline and malignant grades based on a combination of histological parameters (stromal atypia, hypercellularity, mitoses, overgrowth and nature of tumour borders). Surgical margin status was assessed. Clinical follow-up and biostatistical modelling were accomplished.

Results: Of 605 PT, 440 (72.7%) were benign, 111 (18.4%) borderline and 54 (8.9%) malignant. Recurrences, which were predominantly local, were documented in 80 (13.2%) women. Deaths from PT occurred in 12 (2%) women. Multivariate analysis revealed stromal atypia, overgrowth and surgical margins to be independently predictive of clinical behaviour, with mitoses achieving near significance. Stromal hypercellularity and tumour borders were not independently useful. A nomogram developed based on atypia, mitoses, overgrowth and surgical margins (AMOS criteria) could predict recurrence-free survival at 1, 3, 5 and 10 years. This nomogram was superior to a total histological score derived from adding values assigned to each of five histological parameters.

Conclusion: A predictive nomogram based on three histological criteria and surgical margin status can be used to calculate recurrence-free survival of an individual woman diagnosed with PT. This can be applied for patient counselling and clinical management.

Citing Articles

Malignant transformation of recurrent benign phyllodes tumor: a case report and comprehensive review of literature.

Khatiwada A, Bastakoti A, Kc S, Sharma U, Rao S Ann Med Surg (Lond). 2024; 86(12):7469-7473.

PMID: 39649923 PMC: 11623900. DOI: 10.1097/MS9.0000000000002734.


Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted Therapy.

Bansal R, Adeyelu T, Elliott A, Tan A, Ribeiro J, Meisel J JCO Precis Oncol. 2024; 8:e2400289.

PMID: 39637336 PMC: 11634179. DOI: 10.1200/PO.24.00289.


Clinical values of nuclear morphometric analysis in fibroepithelial lesions.

Lee C, Yip H, Li J, Ng J, Tsang J, Loong T Breast Cancer Res. 2024; 26(1):156.

PMID: 39529160 PMC: 11552124. DOI: 10.1186/s13058-024-01912-8.


Prognostic value of Ki67 in phyllodes tumor of the breast: A systematic review and meta‑analysis.

Refai F Exp Ther Med. 2024; 28(6):457.

PMID: 39478738 PMC: 11523259. DOI: 10.3892/etm.2024.12747.


Retrospective analysis of core-needle and vacuum-assisted breast biopsies of B3 fibroepithelial lesions and correlation with results in subsequent surgical specimens.

Nather S, Elfgen C, Rodewald A, Fansa H, Frauchiger-Heuer H, Varga Z J Cancer Res Clin Oncol. 2024; 150(9):436.

PMID: 39340595 PMC: 11438729. DOI: 10.1007/s00432-024-05934-9.